Hospital for Sick Children - Toronto, Ontario
Canada
Ongoing research projects led by Peter Durie, MD, Melvin Freedman,
MD and Johanna Rommens, PhD are aimed towards understanding the deficiencies
in SDS. Information and patient samples are being recruited to survey
and test bone marrow and exercise pancreatic dysfunction in order
to achieve a better understanding of the spectrum and manifestations
of the clinical symptoms in this autosomal recessive disease. Blood
samples from all family members of patients are also being recruited
for ongoing molecular genetic studies geared towards tracking the
chromosomal defects in order to achieve improvement in diagnosis and
care of patients. For further information on this research, please
contact: Lynda Ellis, Research Nurse Coordinator at 416-813-5515 or
E-mail: lynda.ellis@sickkids.ca University
of Texas - Medical Branch - Galveston, Texas
Patients with SDS usually have bone marrow disease that causes decreased
production of blood cells (bone marrow failure). Patients usually
have a low white cell count that may be followed by low blood platelets
and anemia, SDS patients are at risk of developing myelodysplasia
syndrome(MDS). The development of MDS signifies a change in bone marrow
cells that increases the risk for developing acute leukemia. CLICK
HERE FOR FULL DETAILS RESEARCH STUDYNEEDS
YOUR PARTICIPATION
Dr. Akiko Shimamura, MD, PhD., Associate Professor of Pediatrics
at the University of Washington in Seattle, is investigating the
molecular functions of the SBDS protein. The goal of her research
is to understand the causes of bone marrow failure and leukemia
in
Shwachman-Diamond Syndrome and to develop new therapies. Samples
of blood and bone marrow from patients with Shwachman-Diamond Syndrome
are critical for these studies. These samples may be collected when
they are being drawn for clinical care. Dr. Shimamura or Dr. Trisha
Wong would be happy to discuss the study further with anyone interested
in sending a sample. Dr. Shimamura’s e-mail is, shima2@u.washington.ed.
Etiologic Investigation of Cancer Susceptibility in
Inherited Bone Marrow Failure Syndromes (IBMFS)
The National Cancer Institute Institutional Review Board has given
its approval to open a study entitled "Etiologic Investigation
of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes."
The principal investigator responsible for this study is Blanche
P. Alter, MD, MPH. This study is open to patients with SDS, along
with their immediate families. Individuals with one of the inherited
bone marrow failure syndromes, and their parents, brothers, sisters,
and children, are all invited to participate. CLICK
HERE FOR FULL DETAILS
Participation in the Studies of the Molecular Mechanisms
of Bone Marrow Failure
Our study is taking a comprehensive approach to the evaluation of
participants, which is necessary to truly understand the genetic
contribution to the development of disease.
CLICK HERE FOR FULL
DETAILS |